22nd Century Group Inc (XXII) Short Interest Up 0.8% in September

22nd Century Group Inc (NYSE:XXII) was the recipient of a large growth in short interest in the month of September. As of September 29th, there was short interest totalling 7,563,163 shares, a growth of 0.8% from the September 15th total of 7,500,903 shares. Based on an average trading volume of 3,558,908 shares, the short-interest ratio is currently 2.1 days. Approximately 8.8% of the shares of the stock are short sold.

In other news, VP Michael Robert Moynihan sold 50,000 shares of the firm’s stock in a transaction dated Friday, September 29th. The stock was sold at an average price of $2.67, for a total transaction of $133,500.00. Following the sale, the vice president now directly owns 867,220 shares in the company, valued at approximately $2,315,477.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

A number of institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. grew its position in shares of 22nd Century Group by 17.6% in the second quarter. Vanguard Group Inc. now owns 2,894,322 shares of the biotechnology company’s stock valued at $5,065,000 after purchasing an additional 432,450 shares during the last quarter. Virtu KCG Holdings LLC grew its position in shares of 22nd Century Group by 300.9% in the second quarter. Virtu KCG Holdings LLC now owns 126,106 shares of the biotechnology company’s stock valued at $221,000 after purchasing an additional 94,650 shares during the last quarter. Northern Trust Corp grew its position in shares of 22nd Century Group by 22.3% in the second quarter. Northern Trust Corp now owns 133,797 shares of the biotechnology company’s stock valued at $234,000 after purchasing an additional 24,401 shares during the last quarter. Finally, National Asset Management Inc. grew its position in shares of 22nd Century Group by 13.7% in the first quarter. National Asset Management Inc. now owns 172,000 shares of the biotechnology company’s stock valued at $204,000 after purchasing an additional 20,700 shares during the last quarter.

Separately, Zacks Investment Research cut 22nd Century Group from a “hold” rating to a “sell” rating in a research report on Tuesday, September 12th.

22nd Century Group (NYSE:XXII) traded up 1.67% during midday trading on Tuesday, hitting $3.04. The stock had a trading volume of 3,498,237 shares. The stock’s market cap is $312.39 million. 22nd Century Group has a 12 month low of $0.81 and a 12 month high of $3.50. The stock has a 50 day moving average of $2.62 and a 200 day moving average of $1.85.

TRADEMARK VIOLATION NOTICE: This article was originally reported by The Ledger Gazette and is owned by of The Ledge

In other news, VP Michael Robert Moynihan sold 50,000 shares of the firm’s stock in a transaction dated Friday, September 29th. The stock was sold at an average price of $2.67, for a total transaction of $133,500.00. Following the sale, the vice president now directly owns 867,220 shares in the company, valued at approximately $2,315,477.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

A number of institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. grew its position in shares of 22nd Century Group by 17.6% in the second quarter. Vanguard Group Inc. now owns 2,894,322 shares of the biotechnology company’s stock valued at $5,065,000 after purchasing an additional 432,450 shares during the last quarter. Virtu KCG Holdings LLC grew its position in shares of 22nd Century Group by 300.9% in the second quarter. Virtu KCG Holdings LLC now owns 126,106 shares of the biotechnology company’s stock valued at $221,000 after purchasing an additional 94,650 shares during the last quarter. Northern Trust Corp grew its position in shares of 22nd Century Group by 22.3% in the second quarter. Northern Trust Corp now owns 133,797 shares of the biotechnology company’s stock valued at $234,000 after purchasing an additional 24,401 shares during the last quarter. Finally, National Asset Management Inc. grew its position in shares of 22nd Century Group by 13.7% in the first quarter. National Asset Management Inc. now owns 172,000 shares of the biotechnology company’s stock valued at $204,000 after purchasing an additional 20,700 shares during the last quarter.

Separately, Zacks Investment Research cut 22nd Century Group from a “hold” rating to a “sell” rating in a research report on Tuesday, September 12th.

22nd Century Group (NYSE:XXII) traded up 1.67% during midday trading on Tuesday, hitting $3.04. The stock had a trading volume of 3,498,237 shares. The stock’s market cap is $312.39 million. 22nd Century Group has a 12 month low of $0.81 and a 12 month high of $3.50. The stock has a 50 day moving average of $2.62 and a 200 day moving average of $1.85.

TRADEMARK VIOLATION NOTICE: This article was originally reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this article on another website, it was illegally copied and republished in violation of U.S. and international copyright and trademark law. The original version of this article can be accessed at https://ledgergazette.com/2017/10/10/22nd-century-group-inc-xxii-short-interest-up-0-8-in-september.html.

22nd Century Group Company Profile

Receive News & Ratings for 22nd Century Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply